Details for New Drug Application (NDA): 074425
✉ Email this page to a colleague
The generic ingredient in PENTOXIFYLLINE is pentoxifylline. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the pentoxifylline profile page.
Summary for 074425
Tradename: | PENTOXIFYLLINE |
Applicant: | Rising |
Ingredient: | pentoxifylline |
Patents: | 0 |
Pharmacology for NDA: 074425
Physiological Effect | Hematologic Activity Alteration |
Medical Subject Heading (MeSH) Categories for 074425
Suppliers and Packaging for NDA: 074425
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PENTOXIFYLLINE | pentoxifylline | TABLET, EXTENDED RELEASE;ORAL | 074425 | ANDA | Rising Pharma Holdings, Inc. | 16571-856 | 16571-856-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-856-01) |
PENTOXIFYLLINE | pentoxifylline | TABLET, EXTENDED RELEASE;ORAL | 074425 | ANDA | Rising Pharma Holdings, Inc. | 16571-856 | 16571-856-50 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-856-50) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 400MG | ||||
Approval Date: | Jul 8, 1997 | TE: | AB | RLD: | No |
Complete Access Available with Subscription